Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
Grifols Gross Profit (Annual): 2.701B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.701B |
| December 31, 2022 | 2.353B |
| December 31, 2021 | 2.322B |
| December 31, 2020 | 2.575B |
| December 31, 2019 | 2.621B |
| December 31, 2018 | 2.420B |
| December 31, 2017 | 2.437B |
| December 31, 2016 | 2.116B |
| December 31, 2015 | 2.143B |
| December 31, 2014 | 2.260B |
| Date | Value |
|---|---|
| December 31, 2013 | 1.883B |
| December 31, 2012 | 1.709B |
| December 31, 2011 | 1.154B |
| December 31, 2010 | 611.50M |
| December 31, 2009 | 1.034B |
| December 31, 2008 | 937.35M |
| December 31, 2007 | 718.20M |
| December 31, 2006 | 559.99M |
| December 31, 2005 | 460.92M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
2.322B
Minimum
2021
2.701B
Maximum
2023
2.515B
Average
2.575B
Median
2020
Gross Profit (Annual) Benchmarks
| Cellectis SA | 0.018M |
| Adaptimmune Therapeutics PLC | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -4.587M |
| Verona Pharma PLC | 0.00 |